Skip to main content
Cejalvo JM on Muck Rack

Cejalvo JM

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cejalvo

Contact Cejalvo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Patritumab Deruxtecan in Untreated Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study - PubMed

|
By Cejalvo JM, Vila MM, Salvador-Bofill FJ, Luna AM
| ncbi.nlm.nih.gov
doi: 10.1016/j.annonc.2023.05.004. Online ahead of print. Affiliations Affiliations 1 Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain;; SOLTI Breast Cancer Research Group, Barcelona, Spain. 2 SOLTI Breast Cancer Research Group, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, and Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
Open in Who Shared Issue with article?

In the literature: May 2023

|
By Cejalvo JM, A Cervantes, V Gambardella, J-M Cejalvo
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (204) Issue with article?

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer - PubMed

|
By Olivera-Salguero R, Cejalvo JM, Sánchez-Bayona R, Gonzalez-Farre B
| ncbi.nlm.nih.gov
doi: 10.3389/fonc.2023.1151496. Affiliations Affiliations 1 SOLTI Cancer Research Group, Barcelona, Spain. 2 Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain. 3 Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. 4 Hospital Clínico Universitario de Valencia, INCLIVA (Instituto de Investigación Sanitaria), Universidad Valencia, Valencia, Spain.
Open in Who Shared Issue with article?
See all 3 articles